Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

2123 Olorinab
8b503d3afae06fdca05029fe5ba0182d06842b718addaefa9a0dc135c29273e4

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Olorinab (APD371) is a drug being developed by Arena Pharmaceuticals for the treatment of gastrointestinal pain associated with Crohn's disease and irritable bowel syndrome. It acts as a potent and selective cannabinoid CB2 receptor agonist and is claimed to be orally active and peripherally selective. Initial Phase IIa exploratory clinical trials have been successful in patients suffering from quiescent Crohn's disease. Arena initiated the Phase IIb Captivate trial in late July 2019 in patients suffering from irritable bowel syndrome related pain, in constipation and diarrhea predominant sub-types. The Phase IIb trial is expected to enroll 240 participants between the ages of 18 to 70.Three doses of 10 mg, 25 mg, and 50 mg are being tested against Placebo in a 3:4 prescription ratio with a Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) masking layout.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
2122 Next ≫
2124
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan